EVFM: Evofem Biosciences Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
Stocks in this Quantisnow insightHealth Care
Keep researching EVFM
- What is Form 8-K?The SEC "current report" a public company files to disclose material events, generally within four business days of the event.
- Form 8-K explainedWhat a Form 8-K is, when it is due, and what each key item number means, from 1.01 material agreements and 2.02 earnings to 4.02 restatements and 5.02 executive changes.
Quantisnow market dataNASDAQ
EVFM
Evofem Biosciences Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2014
Get push alerts for EVFM
Full EVFM profile on Quantisnow Follow EVFM and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time